Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Phospho-Epha3 (Tyr779) Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA597390
Description
Immunogen sequence: AAYTT; Positive Samples: 293T, Hela; Cellular Location: Cell membrane, Single-pass type I membrane protein.
EPHA3 belongs to the ephrin receptor subfamily of the protein tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediated developmental events, particularly in the nervous system. EPHA3 encodes a protein that binds ephrin-A ligands and receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. EPHA3 binds ephrin-A ligands.
Specifications
Phospho-Epha3 (Tyr779) | |
Polyclonal | |
Unconjugated | |
EPHA3 | |
AW492086; Cek4; EK4; End3; EPH receptor A3; EPHA3; EPH-like kinase 4; Eph-like tyrosine kinase 1; Ephrin type-A receptor 3; ETK; ETK1; H TYRO4; Hek; Hek4; Human embryo kinase; human embryo kinase 1; I79_002835; Mek4; rEK4; testicular tissue protein Li 64; TYRO4; TYRO4 protein tyrosine kinase; tyrosine-protein kinase receptor ETK1; tyrosine-protein kinase receptor REK4; tyrosine-protein kinase TYRO4 | |
Rabbit | |
Affinity Chromatography | |
RUO | |
2042 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
ELISA, Western Blot | |
0.64 mg/mL | |
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3 | |
P29320 | |
EPHA3 | |
A synthetic phosphorylated peptide around Y779 of human EphA3 (NP_0052242). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction